You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

SUMATRIPTAN AND NAPROXEN SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sumatriptan And Naproxen Sodium patents expire, and what generic alternatives are available?

Sumatriptan And Naproxen Sodium is a drug marketed by Aurobindo Pharma Ltd, Rising, and Sun Pharm. and is included in three NDAs.

The generic ingredient in SUMATRIPTAN AND NAPROXEN SODIUM is naproxen sodium; sumatriptan succinate. There are forty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the naproxen sodium; sumatriptan succinate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SUMATRIPTAN AND NAPROXEN SODIUM?
  • What are the global sales for SUMATRIPTAN AND NAPROXEN SODIUM?
  • What is Average Wholesale Price for SUMATRIPTAN AND NAPROXEN SODIUM?
Summary for SUMATRIPTAN AND NAPROXEN SODIUM
Drug patent expirations by year for SUMATRIPTAN AND NAPROXEN SODIUM
Recent Clinical Trials for SUMATRIPTAN AND NAPROXEN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Affiliated Hospital of Qingdao UniversityPhase 3
Jiangsu Provincial People's HospitalPhase 3
West China HospitalPhase 3

See all SUMATRIPTAN AND NAPROXEN SODIUM clinical trials

US Patents and Regulatory Information for SUMATRIPTAN AND NAPROXEN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd SUMATRIPTAN AND NAPROXEN SODIUM naproxen sodium; sumatriptan succinate TABLET;ORAL 207457-001 Feb 15, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising SUMATRIPTAN AND NAPROXEN SODIUM naproxen sodium; sumatriptan succinate TABLET;ORAL 090872-001 Sep 4, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm SUMATRIPTAN AND NAPROXEN SODIUM naproxen sodium; sumatriptan succinate TABLET;ORAL 202803-001 Jul 20, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.